id	sid	eid	entity	type
dpc-2653	2	1	2023;13(1):e2023064 1	CARDINAL
dpc-2653	2	2	anastasia emvalomati1	PERSON
dpc-2653	2	3	oflidou1	PERSON
dpc-2653	2	4	papageorgiou1	PERSON
dpc-2653	2	5	christina kemanetzi1	PERSON
dpc-2653	2	6	maria giannouli1	PERSON
dpc-2653	2	7	kalloniati1	GPE
dpc-2653	2	8	efthymiadis2	PERSON
dpc-2653	2	9	koukoutzeli2	PERSON
dpc-2653	2	10	eleni timotheadou2	PERSON
dpc-2653	2	11	anastasia trigoni1	PERSON
dpc-2653	2	12	aikaterini patsatsi1	PERSON
dpc-2653	2	13	elizabeth lazaridou1	PERSON
dpc-2653	2	14	zoe apalla1	PERSON
dpc-2653	2	15	second	ORDINAL
dpc-2653	2	16	aristotle university	ORG
dpc-2653	2	17	thessaloniki	ORG
dpc-2653	2	18	general hospital	ORG
dpc-2653	2	19	thessaloniki	GPE
dpc-2653	2	20	greece 2	ORG
dpc-2653	2	21	aristotle university	ORG
dpc-2653	2	22	thessaloniki	ORG
dpc-2653	2	23	general hospital	ORG
dpc-2653	2	24	thessaloniki	GPE
dpc-2653	2	25	greece	GPE
dpc-2653	2	26	emvalomati	PERSON
dpc-2653	2	27	papageorgiou	PERSON
dpc-2653	4	1	2023;13(1):e2023064	CARDINAL
dpc-2653	4	2	august 23	DATE
dpc-2653	4	3	2022	CARDINAL
dpc-2653	4	4	january 2023	DATE
dpc-2653	5	1	2023 emvalomati et al	PERSON
dpc-2653	6	1	https://creativecommons.org/licenses/by-nc/4.0/	ORG
dpc-2653	9	1	z. apalla	PERSON
dpc-2653	9	2	m. trakatelli	PERSON
dpc-2653	10	1	myrto trakatelli	PERSON
dpc-2653	10	2	phd	PERSON
dpc-2653	10	3	second	ORDINAL
dpc-2653	10	4	aristotle university	ORG
dpc-2653	10	5	76	CARDINAL
dpc-2653	10	6	564 29	CARDINAL
dpc-2653	10	7	thessaloniki	GPE
dpc-2653	10	8	greece	GPE
dpc-2653	12	1	one	CARDINAL
dpc-2653	13	1	mek	ORG
dpc-2653	14	1	pubmed registry	ORG
dpc-2653	14	2	2021	CARDINAL
dpc-2653	21	1	2	CARDINAL
dpc-2653	22	1	2023;13(1):e2023064	CARDINAL
dpc-2653	22	2	one	CARDINAL
dpc-2653	23	1	1	CARDINAL
dpc-2653	27	1	mek	ORG
dpc-2653	29	1	2021	CARDINAL
dpc-2653	35	1	two	CARDINAL
dpc-2653	38	1	1	CARDINAL
dpc-2653	39	1	2	CARDINAL
dpc-2653	43	1	daily	DATE
dpc-2653	43	2	2	CARDINAL
dpc-2653	45	1	3	CARDINAL
dpc-2653	46	1	20	CARDINAL
dpc-2653	49	1	4	CARDINAL
dpc-2653	50	1	leukonychia	PERSON
dpc-2653	51	1	beau	PERSON
dpc-2653	51	2	melanonychia	PERSON
dpc-2653	52	1	paronychia	GPE
dpc-2653	52	2	5	CARDINAL
dpc-2653	52	3	6	CARDINAL
dpc-2653	54	1	leukonychia	PERSON
dpc-2653	54	2	beau	PERSON
dpc-2653	54	3	710	CARDINAL
dpc-2653	59	1	2023;13(1):e2023064 3	CARDINAL
dpc-2653	59	2	1	CARDINAL
dpc-2653	61	1	a. muehrcke	PERSON
dpc-2653	63	1	c. red-brown	PERSON
dpc-2653	64	1	d. dermoscopic	PERSON
dpc-2653	65	1	e. longitudinal melanonychia	PERSON
dpc-2653	66	1	f. dermoscopy	PERSON
dpc-2653	66	2	melanonychia	PERSON
dpc-2653	66	3	hutchinson	GPE
dpc-2653	69	1	1	CARDINAL
dpc-2653	69	2	38	CARDINAL
dpc-2653	70	1	0	CARDINAL
dpc-2653	70	2	•	CARDINAL
dpc-2653	70	3	• frozen	QUANTITY
dpc-2653	70	4	1	CARDINAL
dpc-2653	70	5	•	CARDINAL
dpc-2653	70	6	•	CARDINAL
dpc-2653	70	7	•	CARDINAL
dpc-2653	70	8	2/3 weeks	DATE
dpc-2653	71	1	2	CARDINAL
dpc-2653	71	2	daily	DATE
dpc-2653	71	3	•	CARDINAL
dpc-2653	71	4	•	CARDINAL
dpc-2653	71	5	•	CARDINAL
dpc-2653	71	6	gram	CARDINAL
dpc-2653	71	7	•	CARDINAL
dpc-2653	71	8	•	CARDINAL
dpc-2653	71	9	•	CARDINAL
dpc-2653	71	10	2 weeks	DATE
dpc-2653	71	11	0	CARDINAL
dpc-2653	71	12	3	CARDINAL
dpc-2653	71	13	daily	DATE
dpc-2653	71	14	0-1	CARDINAL
dpc-2653	71	15	•	CARDINAL
dpc-2653	71	16	gram	CARDINAL
dpc-2653	71	17	•	CARDINAL
dpc-2653	71	18	•	CARDINAL
dpc-2653	71	19	•	CARDINAL
dpc-2653	71	20	2 weeks	DATE
dpc-2653	71	21	4	CARDINAL
dpc-2653	72	1	2023;13(1):e2023064	CARDINAL
dpc-2653	72	2	2	CARDINAL
dpc-2653	73	1	cisplatin carboplatin	PERSON
dpc-2653	73	2	5-fluorouracil	QUANTITY
dpc-2653	73	3	melanonychia onycholysis beau’s	ORG
dpc-2653	73	4	hyperkeratosis hyperpigmentation	ORG
dpc-2653	74	1	half and half	CARDINAL
dpc-2653	74	2	hyperkeratosis pyogenic granuloma subungual &	ORG
dpc-2653	75	1	2023;13(1):e2023064 5	DATE
dpc-2653	77	1	12	CARDINAL
dpc-2653	78	1	beau	PERSON
dpc-2653	79	1	2	CARDINAL
dpc-2653	81	1	17	CARDINAL
dpc-2653	82	1	18	CARDINAL
dpc-2653	83	1	400	CARDINAL
dpc-2653	83	2	between 200 to 300	CARDINAL
dpc-2653	83	3	17	CARDINAL
dpc-2653	84	1	17	CARDINAL
dpc-2653	84	2	2	CARDINAL
dpc-2653	86	1	the pacific yew tree	ORG
dpc-2653	86	2	1992	DATE
dpc-2653	87	1	the european yew tree	ORG
dpc-2653	90	1	80	CARDINAL
dpc-2653	91	1	us	GPE
dpc-2653	91	2	europe	LOC
dpc-2653	92	1	first	ORDINAL
dpc-2653	92	2	weekly	DATE
dpc-2653	92	3	80 mg/m2	QUANTITY
dpc-2653	92	4	the us food and drug administration	ORG
dpc-2653	93	1	100 mg/m2	QUANTITY
dpc-2653	93	2	every three weeks	DATE
dpc-2653	94	1	11	CARDINAL
dpc-2653	96	1	12	CARDINAL
dpc-2653	97	1	beau	PERSON
dpc-2653	97	2	2	CARDINAL
dpc-2653	98	1	cisplatin	PERSON
dpc-2653	98	2	carboplatin	PERSON
dpc-2653	99	1	cisplatin	PERSON
dpc-2653	101	1	carboplatin	ORG
dpc-2653	101	2	13	CARDINAL
dpc-2653	102	1	2	CARDINAL
dpc-2653	103	1	pemetrexed pemetrexed	PERSON
dpc-2653	104	1	melanonychia	PERSON
dpc-2653	105	1	14	CARDINAL
dpc-2653	105	2	2	CARDINAL
dpc-2653	106	1	5-fluorouracil	QUANTITY
dpc-2653	106	2	5-fluorouracil	QUANTITY
dpc-2653	106	3	12	CARDINAL
dpc-2653	107	1	capecitabine	PERSON
dpc-2653	108	1	5-fu	QUANTITY
dpc-2653	108	2	15	CARDINAL
dpc-2653	109	1	5-fu	QUANTITY
dpc-2653	109	2	melanonychia	PERSON
dpc-2653	109	3	half and half	CARDINAL
dpc-2653	109	4	paronychia	ORG
dpc-2653	109	5	16	CARDINAL
dpc-2653	110	1	capecitabine	PERSON
dpc-2653	111	1	16	CARDINAL
dpc-2653	111	2	12	CARDINAL
dpc-2653	111	3	2	CARDINAL
dpc-2653	113	1	6	CARDINAL
dpc-2653	114	1	2023;13(1):e2023064	CARDINAL
dpc-2653	114	2	36	CARDINAL
dpc-2653	115	1	the us food and drug administration	ORG
dpc-2653	118	1	12	CARDINAL
dpc-2653	118	2	2	CARDINAL
dpc-2653	119	1	2	CARDINAL
dpc-2653	120	1	37	CARDINAL
dpc-2653	120	2	38	CARDINAL
dpc-2653	122	1	cetuximab	PERSON
dpc-2653	122	2	panitumumab	PERSON
dpc-2653	122	3	3740	CARDINAL
dpc-2653	123	1	cetuximab	PERSON
dpc-2653	123	2	panitumumab	PERSON
dpc-2653	125	1	3840	CARDINAL
dpc-2653	126	1	second	ORDINAL
dpc-2653	126	2	41	CARDINAL
dpc-2653	127	1	first	ORDINAL
dpc-2653	128	1	37	CARDINAL
dpc-2653	128	2	38	CARDINAL
dpc-2653	128	3	3	CARDINAL
dpc-2653	129	1	1 to 2 months	DATE
dpc-2653	129	2	about 15%	PERCENT
dpc-2653	129	3	38	CARDINAL
dpc-2653	131	1	23%	PERCENT
dpc-2653	131	2	31%	PERCENT
dpc-2653	131	3	gram	CARDINAL
dpc-2653	132	1	37	CARDINAL
dpc-2653	132	2	38	CARDINAL
dpc-2653	134	1	22	CARDINAL
dpc-2653	135	1	up to 30	DATE
dpc-2653	135	2	40%	PERCENT
dpc-2653	135	3	6	CARDINAL
dpc-2653	135	4	23	CARDINAL
dpc-2653	136	1	as high as 89%	PERCENT
dpc-2653	136	2	three	CARDINAL
dpc-2653	136	3	2429	CARDINAL
dpc-2653	137	1	beau	PERSON
dpc-2653	137	2	paronychia	ORG
dpc-2653	137	3	pyogenic granuloma	PERSON
dpc-2653	137	4	koilonychia	PERSON
dpc-2653	137	5	2	CARDINAL
dpc-2653	138	1	130	CARDINAL
dpc-2653	138	2	21	CARDINAL
dpc-2653	138	3	30	CARDINAL
dpc-2653	139	1	fda	ORG
dpc-2653	139	2	ema	ORG
dpc-2653	139	3	30	CARDINAL
dpc-2653	140	1	us	GPE
dpc-2653	141	1	31	CARDINAL
dpc-2653	141	2	32	CARDINAL
dpc-2653	142	1	30	CARDINAL
dpc-2653	142	2	33	DATE
dpc-2653	143	1	el®	ORG
dpc-2653	143	2	30	CARDINAL
dpc-2653	145	1	34	CARDINAL
dpc-2653	146	1	19.4%	PERCENT
dpc-2653	146	2	95%	PERCENT
dpc-2653	146	3	11.8-30.3%	PERCENT
dpc-2653	147	1	35	CARDINAL
dpc-2653	148	1	madagascar	GPE
dpc-2653	149	1	the united states	GPE
dpc-2653	150	1	12	CARDINAL
dpc-2653	151	1	beau	PERSON
dpc-2653	151	2	2	CARDINAL
dpc-2653	154	1	2023;13(1):e2023064	CARDINAL
dpc-2653	154	2	bruton	PERSON
dpc-2653	154	3	bruton	PERSON
dpc-2653	156	1	about 2/3	CARDINAL
dpc-2653	156	2	38	CARDINAL
dpc-2653	156	3	3	CARDINAL
dpc-2653	157	1	anti-her2	NORP
dpc-2653	157	2	2	CARDINAL
dpc-2653	157	3	anti-her2	NORP
dpc-2653	158	1	trastuzumab	PERSON
dpc-2653	158	2	37	CARDINAL
dpc-2653	158	3	38	CARDINAL
dpc-2653	159	1	lapatinib	PERSON
dpc-2653	159	2	afatinib	PERSON
dpc-2653	159	3	paronychia	ORG
dpc-2653	159	4	pyogenic granuloma	ORG
dpc-2653	159	5	37	CARDINAL
dpc-2653	159	6	38	CARDINAL
dpc-2653	159	7	3	CARDINAL
dpc-2653	160	1	anti-mek	NORP
dpc-2653	160	2	cobimetinib	ORG
dpc-2653	161	1	38	CARDINAL
dpc-2653	163	1	38	CARDINAL
dpc-2653	164	1	sorafenib	PERSON
dpc-2653	166	1	the first 2 months	DATE
dpc-2653	166	2	70%	PERCENT
dpc-2653	166	3	25%	PERCENT
dpc-2653	166	4	41	CARDINAL
dpc-2653	166	5	3	CARDINAL
dpc-2653	168	1	sunitinib intake	PERSON
dpc-2653	169	1	38	CARDINAL
dpc-2653	169	2	41	CARDINAL
dpc-2653	170	1	2	CARDINAL
dpc-2653	172	1	a. paronychia	PERSON
dpc-2653	176	1	f. acute photo	PERSON
dpc-2653	178	1	8	CARDINAL
dpc-2653	179	1	2023;13(1):e2023064	CARDINAL
dpc-2653	179	2	paronychia	GPE
dpc-2653	179	3	pyogenic granuloma	ORG
dpc-2653	180	1	38	CARDINAL
dpc-2653	180	2	3	CARDINAL
dpc-2653	181	1	ret	ORG
dpc-2653	181	2	ret	ORG
dpc-2653	183	1	38	CARDINAL
dpc-2653	183	2	41	CARDINAL
dpc-2653	184	1	two	CARDINAL
dpc-2653	184	2	mtorc1	PERSON
dpc-2653	184	3	mtorc2	ORG
dpc-2653	185	1	38	CARDINAL
dpc-2653	186	1	everolimus	PERSON
dpc-2653	186	2	3	CARDINAL
dpc-2653	187	1	38	CARDINAL
dpc-2653	188	1	erbb1	EVENT
dpc-2653	188	2	cetuximab panitumumab	PERSON
dpc-2653	188	3	necitumumab paronychia pyogenic granuloma	PERSON
dpc-2653	188	4	anti-her2 her2	NORP
dpc-2653	188	5	erbb1-4	DATE
dpc-2653	188	6	lapatinib afatinib dacomitinib paronychia pyogenic granuloma	PERSON
dpc-2653	188	7	anti-mek	NORP
dpc-2653	188	8	1/2	CARDINAL
dpc-2653	188	9	trametinib	ORG
dpc-2653	188	10	cobimetinib selumetinib paronychia pyogenic granuloma slower	ORG
dpc-2653	188	11	paronychia pyogenic granuloma	ORG
dpc-2653	188	12	1-3 pdgfr α	QUANTITY
dpc-2653	188	13	sunitinib sorafenib cabozantinib axitinib pazotinib	PERSON
dpc-2653	188	14	ret	ORG
dpc-2653	189	1	2/3	CARDINAL
dpc-2653	189	2	ret	ORG
dpc-2653	189	3	paronychia pyogenic granuloma photoonycholysis	PERSON
dpc-2653	189	4	bcr-abl	ORG
dpc-2653	189	5	bcr-abl	ORG
dpc-2653	189	6	melanonychia	PERSON
dpc-2653	189	7	bruton	PERSON
dpc-2653	189	8	bruton	PERSON
dpc-2653	191	1	2023;13(1):e2023064 9	TIME
dpc-2653	193	1	3	CARDINAL
dpc-2653	201	1	24	CARDINAL
dpc-2653	202	1	ret	ORG
dpc-2653	202	2	egf	ORG
dpc-2653	203	1	1	CARDINAL
dpc-2653	203	2	38	CARDINAL
dpc-2653	203	3	3	CARDINAL
dpc-2653	204	1	uva	ORG
dpc-2653	205	1	bcr-abl	ORG
dpc-2653	205	2	bcr-abl	ORG
dpc-2653	205	3	the c-abl proto-oncogene	ORG
dpc-2653	205	4	philadelphia	GPE
dpc-2653	206	1	38	CARDINAL
dpc-2653	207	1	melanonychia	ORG
dpc-2653	207	2	lichenoid	ORG
dpc-2653	207	3	3	CARDINAL
dpc-2653	208	1	melanonychia	PERSON
dpc-2653	208	2	1-2 months	DATE
dpc-2653	210	1	melanonychia	PERSON
dpc-2653	210	2	melanonychia	PERSON
dpc-2653	211	1	several months	DATE
dpc-2653	211	2	38	CARDINAL
dpc-2653	212	1	3	CARDINAL
dpc-2653	214	1	a. psoriatic	PERSON
dpc-2653	216	1	d. lichenoid	PERSON
dpc-2653	220	1	10	CARDINAL
dpc-2653	221	1	2023;13(1):e2023064	CARDINAL
dpc-2653	221	2	first	ORDINAL
dpc-2653	222	1	43	CARDINAL
dpc-2653	222	2	45	CARDINAL
dpc-2653	224	1	4	CARDINAL
dpc-2653	225	1	melanonychia melanonychia	PERSON
dpc-2653	225	2	one	CARDINAL
dpc-2653	226	1	saraswat et al	PERSON
dpc-2653	227	1	4	CARDINAL
dpc-2653	228	1	1	CARDINAL
dpc-2653	229	1	1–2 months	DATE
dpc-2653	231	1	melanonychia	PERSON
dpc-2653	231	2	4649	CARDINAL
dpc-2653	232	1	melanonychia striata	ORG
dpc-2653	232	2	melanonychia	PERSON
dpc-2653	233	1	melanonychia	PERSON
dpc-2653	233	2	2	CARDINAL
dpc-2653	235	1	16	CARDINAL
dpc-2653	235	2	38	DATE
dpc-2653	235	3	5	CARDINAL
dpc-2653	236	1	several months	DATE
dpc-2653	237	1	polish	NORP
dpc-2653	238	1	beau	PERSON
dpc-2653	239	1	4	CARDINAL
dpc-2653	239	2	1	CARDINAL
dpc-2653	239	3	1	CARDINAL
dpc-2653	242	1	cd4+/cd8	ORG
dpc-2653	242	2	4244	CARDINAL
dpc-2653	243	1	pd-1/pd-l1	FAC
dpc-2653	244	1	cpis	PERSON
dpc-2653	244	2	pembrolizumab	PERSON
dpc-2653	244	3	anti-pd-l1	NORP
dpc-2653	244	4	durvalumab	PERSON
dpc-2653	245	1	4244	CARDINAL
dpc-2653	247	1	several months	DATE
dpc-2653	248	1	42	CARDINAL
dpc-2653	251	1	more than one	CARDINAL
dpc-2653	252	1	42	CARDINAL
dpc-2653	252	2	45	CARDINAL
dpc-2653	254	1	two	CARDINAL
dpc-2653	256	1	43	CARDINAL
dpc-2653	256	2	45	CARDINAL
dpc-2653	257	1	4	CARDINAL
dpc-2653	258	1	2	CARDINAL
dpc-2653	258	2	3	DATE
dpc-2653	258	3	7	DATE
dpc-2653	258	4	81	CARDINAL
dpc-2653	258	5	1	CARDINAL
dpc-2653	258	6	several weeks	DATE
dpc-2653	258	7	2	CARDINAL
dpc-2653	259	1	3	CARDINAL
dpc-2653	259	2	4	CARDINAL
dpc-2653	260	1	5	CARDINAL
dpc-2653	260	2	6	CARDINAL
dpc-2653	261	1	7	CARDINAL
dpc-2653	264	1	2023;13(1):e2023064 11	CARDINAL
dpc-2653	264	2	5	CARDINAL
dpc-2653	266	1	carboplatin	PERSON
dpc-2653	266	2	5-fluorouracil	QUANTITY
dpc-2653	266	3	pemetrexed	ORG
dpc-2653	266	4	melanonychia	ORG
dpc-2653	266	5	tegafur	GPE
dpc-2653	266	6	cisplatin	PERSON
dpc-2653	266	7	half and half	CARDINAL
dpc-2653	266	8	5	CARDINAL
dpc-2653	266	9	5-fluorouracil	QUANTITY
dpc-2653	266	10	capecitabine cetuximab	PERSON
dpc-2653	266	11	panitumumab	PERSON
dpc-2653	266	12	necituumab	PERSON
dpc-2653	266	13	afatinib	PERSON
dpc-2653	266	14	trametinib	ORG
dpc-2653	266	15	cobimetinib	ORG
dpc-2653	266	16	everolimus	GPE
dpc-2653	266	17	temsirolimus	GPE
dpc-2653	266	18	ibrutinib	PERSON
dpc-2653	266	19	etoposide cetuximab	PERSON
dpc-2653	266	20	panitumumab	PERSON
dpc-2653	266	21	necituumab	PERSON
dpc-2653	266	22	afatinib	PERSON
dpc-2653	266	23	trametinib	ORG
dpc-2653	266	24	cobimetinib	ORG
dpc-2653	266	25	everolimus	GPE
dpc-2653	266	26	cetuximab	PERSON
dpc-2653	266	27	panitumumab	PERSON
dpc-2653	266	28	necituumab	PERSON
dpc-2653	266	29	afatinib	PERSON
dpc-2653	266	30	trametinib	ORG
dpc-2653	266	31	cobimetinib	ORG
dpc-2653	266	32	everolimus	GPE
dpc-2653	266	33	temsirolimus	GPE
dpc-2653	266	34	cetuximab	PERSON
dpc-2653	266	35	panitumumab	PERSON
dpc-2653	266	36	necituumab	PERSON
dpc-2653	266	37	afatinib	PERSON
dpc-2653	266	38	trametinib	ORG
dpc-2653	266	39	cobimetinib	ORG
dpc-2653	266	40	everolimus temsirolimus	PERSON
dpc-2653	266	41	ibrutinib	PERSON
dpc-2653	266	42	ibrutinib koilonychia	PERSON
dpc-2653	266	43	12	CARDINAL
dpc-2653	267	1	2023;13(1):e2023064	CARDINAL
dpc-2653	269	1	leukonychia	PERSON
dpc-2653	270	1	63	CARDINAL
dpc-2653	270	2	64	CARDINAL
dpc-2653	271	1	leukonychia	PERSON
dpc-2653	272	1	leukonychia	PERSON
dpc-2653	273	1	leukonychia	PERSON
dpc-2653	275	1	leukonychia	PERSON
dpc-2653	275	2	three	CARDINAL
dpc-2653	275	3	half and half	CARDINAL
dpc-2653	275	4	terry	PERSON
dpc-2653	276	1	a. muehrcke	PERSON
dpc-2653	277	1	chen et al	PERSON
dpc-2653	278	1	6	CARDINAL
dpc-2653	279	1	less than 2 mg	QUANTITY
dpc-2653	279	2	second	ORDINAL
dpc-2653	279	3	third	ORDINAL
dpc-2653	279	4	fourth	ORDINAL
dpc-2653	283	1	6	CARDINAL
dpc-2653	284	1	b. half and half	CARDINAL
dpc-2653	284	2	20%–60%	PERCENT
dpc-2653	286	1	c. terry’s	PERSON
dpc-2653	287	1	leukonychia	PERSON
dpc-2653	287	2	melanonychia	PERSON
dpc-2653	290	1	beau	PERSON
dpc-2653	291	1	4648	CARDINAL
dpc-2653	292	1	beau	PERSON
dpc-2653	292	2	a few weeks	DATE
dpc-2653	292	3	4	CARDINAL
dpc-2653	292	4	55	DATE
dpc-2653	296	1	beau	PERSON
dpc-2653	296	2	4	CARDINAL
dpc-2653	296	3	56	DATE
dpc-2653	296	4	57	DATE
dpc-2653	296	5	5	CARDINAL
dpc-2653	299	1	more than 2 weeks	DATE
dpc-2653	303	1	1–2 weeks	DATE
dpc-2653	304	1	beau	PERSON
dpc-2653	304	2	beau	PERSON
dpc-2653	305	1	two	CARDINAL
dpc-2653	305	2	58	CARDINAL
dpc-2653	306	1	59	CARDINAL
dpc-2653	306	2	60	CARDINAL
dpc-2653	307	1	kochupillai et al	PERSON
dpc-2653	308	1	61	CARDINAL
dpc-2653	309	1	only five	CARDINAL
dpc-2653	310	1	saraswat et al	GPE
dpc-2653	311	1	5	CARDINAL
dpc-2653	312	1	leukonychia leukonychia	PERSON
dpc-2653	312	2	leukonychia	PERSON
dpc-2653	313	1	leukonychia	PERSON
dpc-2653	313	2	leukonychia	PERSON
dpc-2653	313	3	10	CARDINAL
dpc-2653	313	4	4648	DATE
dpc-2653	313	5	62	CARDINAL
dpc-2653	315	1	2023;13(1):e2023064 13	DATE
dpc-2653	315	2	29	CARDINAL
dpc-2653	315	3	46	DATE
dpc-2653	315	4	47	DATE
dpc-2653	315	5	59	CARDINAL
dpc-2653	316	1	weekly	DATE
dpc-2653	316	2	3-week	DATE
dpc-2653	316	3	29	CARDINAL
dpc-2653	316	4	46	DATE
dpc-2653	317	1	57	CARDINAL
dpc-2653	317	2	59	DATE
dpc-2653	317	3	60	CARDINAL
dpc-2653	318	1	29	CARDINAL
dpc-2653	318	2	59	DATE
dpc-2653	318	3	6972	DATE
dpc-2653	319	1	onycholysis	PERSON
dpc-2653	320	1	22	CARDINAL
dpc-2653	320	2	26	DATE
dpc-2653	320	3	48	DATE
dpc-2653	320	4	60	DATE
dpc-2653	320	5	71	CARDINAL
dpc-2653	322	1	29	CARDINAL
dpc-2653	323	1	achille	PERSON
dpc-2653	324	1	22	CARDINAL
dpc-2653	324	2	24	CARDINAL
dpc-2653	325	1	melanonychia	ORG
dpc-2653	325	2	beau	PERSON
dpc-2653	325	3	koilonychias	PERSON
dpc-2653	325	4	leukonychia	PERSON
dpc-2653	326	1	22	CARDINAL
dpc-2653	326	2	24	DATE
dpc-2653	326	3	26	DATE
dpc-2653	326	4	47	DATE
dpc-2653	329	1	24	CARDINAL
dpc-2653	329	2	47	DATE
dpc-2653	331	1	22	CARDINAL
dpc-2653	332	1	59	CARDINAL
dpc-2653	334	1	73	CARDINAL
dpc-2653	336	1	34	CARDINAL
dpc-2653	337	1	1 hour	TIME
dpc-2653	338	1	weekly	DATE
dpc-2653	338	2	1-hour	TIME
dpc-2653	338	3	3-week	DATE
dpc-2653	338	4	3-hour	TIME
dpc-2653	342	1	5	CARDINAL
dpc-2653	343	1	muehrcke	PERSON
dpc-2653	343	2	cisplatin	PERSON
dpc-2653	344	1	68	CARDINAL
dpc-2653	344	2	5	CARDINAL
dpc-2653	345	1	0.12 mm	QUANTITY
dpc-2653	345	2	23	CARDINAL
dpc-2653	347	1	leukonychia	PERSON
dpc-2653	347	2	23	CARDINAL
dpc-2653	347	3	66	CARDINAL
dpc-2653	349	1	48	CARDINAL
dpc-2653	352	1	22	CARDINAL
dpc-2653	352	2	25	DATE
dpc-2653	352	3	26	DATE
dpc-2653	352	4	46	CARDINAL
dpc-2653	352	5	59	CARDINAL
dpc-2653	354	1	24	CARDINAL
dpc-2653	354	2	46	DATE
dpc-2653	354	3	48	DATE
dpc-2653	355	1	cetuximab	PERSON
dpc-2653	355	2	panitumumab	PERSON
dpc-2653	355	3	necitumumab	PERSON
dpc-2653	355	4	afatinib	PERSON
dpc-2653	355	5	trametinib	ORG
dpc-2653	355	6	cobimetinib	ORG
dpc-2653	355	7	everolimus	GPE
dpc-2653	355	8	temsirolimus	GPE
dpc-2653	355	9	ibrutinib	PERSON
dpc-2653	355	10	38	CARDINAL
dpc-2653	355	11	5	CARDINAL
dpc-2653	356	1	onycholysis	PERSON
dpc-2653	356	2	22	CARDINAL
dpc-2653	357	1	35	CARDINAL
dpc-2653	357	2	43.7%	PERCENT
dpc-2653	357	3	95%	PERCENT
dpc-2653	357	4	18.0-73.3%	PERCENT
dpc-2653	357	5	34.9%	PERCENT
dpc-2653	357	6	95%	PERCENT
dpc-2653	357	7	29.9-40.2%	PERCENT
dpc-2653	358	1	77.74	CARDINAL
dpc-2653	358	2	95%	PERCENT
dpc-2653	358	3	41.88-144.32	CARDINAL
dpc-2653	358	4	22	CARDINAL
dpc-2653	359	1	several weeks	DATE
dpc-2653	359	2	29	CARDINAL
dpc-2653	360	1	weekly	DATE
dpc-2653	360	2	14	CARDINAL
dpc-2653	361	1	2023;13(1):e2023064	CARDINAL
dpc-2653	362	1	5	CARDINAL
dpc-2653	369	1	healthcare	ORG
dpc-2653	377	1	48	CARDINAL
dpc-2653	379	1	25	CARDINAL
dpc-2653	379	2	51% to 11%	PERCENT
dpc-2653	379	3	21%	PERCENT
dpc-2653	379	4	0%	PERCENT
dpc-2653	380	1	2	CARDINAL
dpc-2653	380	2	aes	ORG
dpc-2653	380	3	22%	PERCENT
dpc-2653	380	4	0%	PERCENT
dpc-2653	381	1	25	CARDINAL
dpc-2653	382	1	25	CARDINAL
dpc-2653	383	1	27	CARDINAL
dpc-2653	386	1	4	CARDINAL
dpc-2653	386	2	daily	DATE
dpc-2653	386	3	28	CARDINAL
dpc-2653	386	4	29	CARDINAL
dpc-2653	387	1	daily	DATE
dpc-2653	388	1	38	CARDINAL
dpc-2653	388	2	1	CARDINAL
dpc-2653	389	1	onycholysis	PERSON
dpc-2653	389	2	22	CARDINAL
dpc-2653	391	1	paronychia paronychia	PERSON
dpc-2653	392	1	one	CARDINAL
dpc-2653	393	1	2	CARDINAL
dpc-2653	393	2	8	CARDINAL
dpc-2653	394	1	paronychia	ORG
dpc-2653	395	1	75	CARDINAL
dpc-2653	395	2	76	DATE
dpc-2653	396	1	ret	ORG
dpc-2653	396	2	anti-mek	NORP
dpc-2653	396	3	5-fluorouracil	QUANTITY
dpc-2653	396	4	4	CARDINAL
dpc-2653	396	5	5	CARDINAL
dpc-2653	398	1	koilonychia	PERSON
dpc-2653	398	2	74	CARDINAL
dpc-2653	399	1	cetuximab	PERSON
dpc-2653	399	2	panitumumab	PERSON
dpc-2653	399	3	necitumumab	PERSON
dpc-2653	399	4	afatinib	PERSON
dpc-2653	399	5	trametinib	ORG
dpc-2653	399	6	cobimetinib	ORG
dpc-2653	399	7	everolimus	GPE
dpc-2653	399	8	temsirolimus	GPE
dpc-2653	399	9	5	CARDINAL
dpc-2653	400	1	koilonychia	PERSON
dpc-2653	401	1	greek	NORP
dpc-2653	401	2	koilos	PERSON
dpc-2653	402	1	koilonychia	PERSON
dpc-2653	403	1	koilonychia	PERSON
dpc-2653	405	1	koilonychia	NORP
dpc-2653	407	1	koilonychia	PERSON
dpc-2653	407	2	5	CARDINAL
dpc-2653	409	1	2023;13(1):e2023064 15	CARDINAL
dpc-2653	411	1	77	CARDINAL
dpc-2653	420	1	48	CARDINAL
dpc-2653	424	1	huang et al	PERSON
dpc-2653	425	1	77	CARDINAL
dpc-2653	427	1	79	CARDINAL
dpc-2653	427	2	80	DATE
dpc-2653	428	1	79	CARDINAL
dpc-2653	428	2	80	DATE
dpc-2653	429	1	4	CARDINAL
dpc-2653	429	2	a. onycholysis	PERSON
dpc-2653	431	1	16	CARDINAL
dpc-2653	432	1	2023;13(1):e2023064 14	DATE
dpc-2653	434	1	melanonychia	PERSON
dpc-2653	436	1	2007;6(2):95–6	CARDINAL
dpc-2653	437	1	15	CARDINAL
dpc-2653	437	2	malet-martino	PERSON
dpc-2653	437	3	martino r.	PERSON
dpc-2653	437	4	three	CARDINAL
dpc-2653	437	5	5	CARDINAL
dpc-2653	437	6	uft	GPE
dpc-2653	438	1	7	CARDINAL
dpc-2653	439	1	2002	DATE
dpc-2653	440	1	288–323	CARDINAL
dpc-2653	441	1	16	CARDINAL
dpc-2653	442	1	garcia-diez	PERSON
dpc-2653	442	2	j. mucocutaneous	PERSON
dpc-2653	442	3	3	CARDINAL
dpc-2653	443	1	j am	PERSON
dpc-2653	444	1	2000;42(4):699	CARDINAL
dpc-2653	445	1	17	CARDINAL
dpc-2653	446	1	yamamoto t. bleomycin	PERSON
dpc-2653	448	1	2006;155(5):869–75	CARDINAL
dpc-2653	448	2	18	CARDINAL
dpc-2653	449	1	turan erkek e	ORG
dpc-2653	449	2	yılmaz g	PERSON
dpc-2653	449	3	e. bleomycin-induced	PERSON
dpc-2653	450	1	turkish	NORP
dpc-2653	450	2	turkish	NORP
dpc-2653	451	1	2019;36(2):138–40	CARDINAL
dpc-2653	451	2	19	CARDINAL
dpc-2653	451	3	cortes je	PERSON
dpc-2653	451	4	r. docetaxel	PERSON
dpc-2653	452	1	j clin oncol	PERSON
dpc-2653	453	1	1995;13(10):2643–55	CARDINAL
dpc-2653	455	1	gelmon k.	PERSON
dpc-2653	457	1	lancet	ORG
dpc-2653	459	1	von hoff dd	PERSON
dpc-2653	459	2	ervin t	PERSON
dpc-2653	459	3	moore	PERSON
dpc-2653	461	1	2013;369(18):1691–703	CARDINAL
dpc-2653	461	2	22	CARDINAL
dpc-2653	462	1	roche h	ORG
dpc-2653	462	2	belum vr	PERSON
dpc-2653	465	1	2016;26(5):427–43. 23	CARDINAL
dpc-2653	468	1	2011;37:2010–1	DATE
dpc-2653	469	1	24	CARDINAL
dpc-2653	470	1	miller kk	PERSON
dpc-2653	470	2	gorcey l	ORG
dpc-2653	471	1	j am	PERSON
dpc-2653	473	1	25	CARDINAL
dpc-2653	474	1	scotté	PERSON
dpc-2653	474	2	tourani jm	PERSON
dpc-2653	474	3	marsan s	PERSON
dpc-2653	476	1	j clin oncol	PERSON
dpc-2653	477	1	2005;23(19):4424–9	CARDINAL
dpc-2653	477	2	26	CARDINAL
dpc-2653	478	1	minisini	PERSON
dpc-2653	478	2	piraccini bm	PERSON
dpc-2653	479	1	ann oncol	PERSON
dpc-2653	480	1	2003;14(2):333–7	CARDINAL
dpc-2653	481	1	27	CARDINAL
dpc-2653	482	1	matsumoto k	PERSON
dpc-2653	482	2	hino	PERSON
dpc-2653	482	3	fukuda k	PERSON
dpc-2653	482	4	hirokaga k	PERSON
dpc-2653	483	1	28	CARDINAL
dpc-2653	484	1	i. taxane	PERSON
dpc-2653	486	1	2012;16(3):270–5	CARDINAL
dpc-2653	487	1	29	CARDINAL
dpc-2653	488	1	winther	ORG
dpc-2653	488	2	knap m	ORG
dpc-2653	488	3	jensen ab	PERSON
dpc-2653	491	1	2007;15(10):1191–7	CARDINAL
dpc-2653	491	2	30	CARDINAL
dpc-2653	491	3	cecco s	PERSON
dpc-2653	491	4	baldo p	PERSON
dpc-2653	491	5	giacomin e	PERSON
dpc-2653	491	6	leone r. safety	PERSON
dpc-2653	492	1	opin drug	PERSON
dpc-2653	493	1	2014;13(4):511–20.	DATE
dpc-2653	495	1	socinski ma	PERSON
dpc-2653	495	2	karaseva na	PERSON
dpc-2653	495	3	makhson	PERSON
dpc-2653	495	4	okamoto	PERSON
dpc-2653	496	1	weekly	DATE
dpc-2653	496	2	carboplatin	ORG
dpc-2653	496	3	first	ORDINAL
dpc-2653	497	1	j clin oncol	PERSON
dpc-2653	504	1	1	CARDINAL
dpc-2653	504	2	kambil s	PERSON
dpc-2653	504	3	r.	NORP
dpc-2653	505	1	indian	NORP
dpc-2653	506	1	2015;81(4):434	CARDINAL
dpc-2653	507	1	2	CARDINAL
dpc-2653	507	2	piraccini bm	PERSON
dpc-2653	507	3	tosti a. drug-	PERSON
dpc-2653	510	1	3	CARDINAL
dpc-2653	510	2	hinds g	PERSON
dpc-2653	510	3	thomas	PERSON
dpc-2653	513	1	4	CARDINAL
dpc-2653	513	2	saraswat n	ORG
dpc-2653	513	3	kumar d	PERSON
dpc-2653	514	1	kumar s.	PERSON
dpc-2653	515	1	indian	NORP
dpc-2653	517	1	2020	DATE
dpc-2653	517	2	1	CARDINAL
dpc-2653	517	3	2021	CARDINAL
dpc-2653	518	1	5	CARDINAL
dpc-2653	519	1	daniel cr	PERSON
dpc-2653	519	2	scher rk	PERSON
dpc-2653	521	1	j am	PERSON
dpc-2653	522	1	1984;10(2):250–8	CARDINAL
dpc-2653	523	1	6	CARDINAL
dpc-2653	523	2	chen w	PERSON
dpc-2653	523	3	yu ys	PERSON
dpc-2653	523	4	liu yh	PERSON
dpc-2653	523	5	sheen jm	PERSON
dpc-2653	523	6	hsiao cc	PERSON
dpc-2653	525	1	2007;21(2):186–90.	DATE
dpc-2653	525	2	7	CARDINAL
dpc-2653	525	3	piraccini bm	PERSON
dpc-2653	526	1	dermatol clin	PERSON
dpc-2653	527	1	2006;24(3):387–91	DATE
dpc-2653	527	2	8	CARDINAL
dpc-2653	527	3	piraccini bm	PERSON
dpc-2653	527	4	iorizzo m. drug	PERSON
dpc-2653	528	1	dermatol clin	PERSON
dpc-2653	529	1	2007;25(2):215–21	CARDINAL
dpc-2653	529	2	9	CARDINAL
dpc-2653	529	3	piraccini bm	PERSON
dpc-2653	530	1	opin drug saf	PERSON
dpc-2653	530	2	2004;3(1):57–65	CARDINAL
dpc-2653	531	1	10	CARDINAL
dpc-2653	532	1	scher rk	PERSON
dpc-2653	534	1	2004;18(2):124–5	CARDINAL
dpc-2653	535	1	11	CARDINAL
dpc-2653	536	1	kirby	PERSON
dpc-2653	538	1	2010	DATE
dpc-2653	539	1	12	CARDINAL
dpc-2653	540	1	reyes-habito cm	ORG
dpc-2653	540	2	roh ek	PERSON
dpc-2653	540	3	i.	PERSON
dpc-2653	541	1	j am	PERSON
dpc-2653	543	1	2014;71(2):203.e1-203.e12	CARDINAL
dpc-2653	543	2	http:// dx.doi.org/10.1016/j.jaad.2014.04.014 13	PERSON
dpc-2653	544	1	n, naik h	ORG
dpc-2653	544	2	burgin s. chemotherapeutic agents	PERSON
dpc-2653	545	1	j am	PERSON
dpc-2653	546	1	2008;58(4):545–70	CARDINAL
dpc-2653	548	1	2023;13(1):e2023064 17 48	DATE
dpc-2653	549	1	robert c	PERSON
dpc-2653	549	2	mateus	PERSON
dpc-2653	549	3	charles c	PERSON
dpc-2653	553	1	49	DATE
dpc-2653	554	1	fricain jc	PERSON
dpc-2653	554	2	robert c. pigmentary	PERSON
dpc-2653	557	1	ann dermatol venereol	PERSON
dpc-2653	559	1	50	CARDINAL
dpc-2653	559	2	harrison bm	PERSON
dpc-2653	559	3	cbs	ORG
dpc-2653	561	1	51	CARDINAL
dpc-2653	562	1	shah pc	PERSON
dpc-2653	562	2	rao krp	ORG
dpc-2653	562	3	patel ar	ORG
dpc-2653	565	1	52	CARDINAL
dpc-2653	566	1	adam ba	PERSON
dpc-2653	568	1	singapore	GPE
dpc-2653	568	2	j. 1981;22(1):35–7	PERSON
dpc-2653	569	1	53	CARDINAL
dpc-2653	570	1	rao krp	ORG
dpc-2653	571	1	j haematol	PERSON
dpc-2653	572	1	2002;117(1):2.	CARDINAL
dpc-2653	572	2	54	CARDINAL
dpc-2653	573	1	dave s	PERSON
dpc-2653	573	2	thappa dm.	ORG
dpc-2653	574	1	j. 2003;9(3):148–51.	PERSON
dpc-2653	575	1	55	DATE
dpc-2653	576	1	valero	ORG
dpc-2653	576	2	holmes fa	PERSON
dpc-2653	576	3	walters rs	PERSON
dpc-2653	576	4	theriault	PERSON
dpc-2653	576	5	esparza l	PERSON
dpc-2653	577	1	j clin oncol	PERSON
dpc-2653	578	1	1995;13(12):2886–94	CARDINAL
dpc-2653	579	1	56	CARDINAL
dpc-2653	579	2	d. british journal of dermatology	ORG
dpc-2653	579	3	2002	DATE
dpc-2653	579	4	146	CARDINAL
dpc-2653	579	5	705	CARDINAL
dpc-2653	579	6	718	CARDINAL
dpc-2653	580	1	mourad ya	PERSON
dpc-2653	580	2	matta-muallem	NORP
dpc-2653	580	3	shamseddine a.	PERSON
dpc-2653	581	1	j. 2003;9(3):152–4.	ORG
dpc-2653	581	2	58	DATE
dpc-2653	582	1	hardin	GPE
dpc-2653	582	2	haber rm	PERSON
dpc-2653	584	1	2015;172(3):592–6	CARDINAL
dpc-2653	585	1	59	CARDINAL
dpc-2653	586	1	hussain s	PERSON
dpc-2653	586	2	anderson dn	PERSON
dpc-2653	586	3	adamson b	PERSON
dpc-2653	586	4	mcmanus m	PERSON
dpc-2653	588	1	2000;88(10):2367–71	CARDINAL
dpc-2653	589	1	60	CARDINAL
dpc-2653	589	2	maino kl	PERSON
dpc-2653	589	3	norwood	ORG
dpc-2653	592	1	2003;72(3):234–6	CARDINAL
dpc-2653	594	1	kochupillai	PERSON
dpc-2653	594	2	prabhu m	PERSON
dpc-2653	596	1	1983;70(2):137–137	CARDINAL
dpc-2653	597	1	62	CARDINAL
dpc-2653	598	1	leukonychia	PERSON
dpc-2653	600	1	2010;37(2):188–9	CARDINAL
dpc-2653	601	1	63	DATE
dpc-2653	602	1	parakh	PERSON
dpc-2653	602	2	kocchar	PERSON
dpc-2653	603	1	leukonychia	PERSON
dpc-2653	604	1	indian	NORP
dpc-2653	605	1	2007;44(11):865	ORDINAL
dpc-2653	605	2	64	CARDINAL
dpc-2653	606	1	mirfazaelian	ORG
dpc-2653	606	2	daneshbod y. mees	PERSON
dpc-2653	610	1	kumar s	PERSON
dpc-2653	610	2	diwan s	PERSON
dpc-2653	610	3	goyal s. mees	PERSON
dpc-2653	612	1	66	CARDINAL
dpc-2653	613	1	shelley wb	PERSON
dpc-2653	613	2	humphrey gb	PERSON
dpc-2653	614	1	leukonychia	PERSON
dpc-2653	616	1	1997;14(2):144–5	CARDINAL
dpc-2653	617	1	67	CARDINAL
dpc-2653	619	1	2018;379(16):1561–1561.	CARDINAL
dpc-2653	620	1	68	CARDINAL
dpc-2653	622	1	beau	PERSON
dpc-2653	623	1	j. 2006;12(6):5–7.	ORG
dpc-2653	624	1	69	CARDINAL
dpc-2653	625	1	scotté	PERSON
dpc-2653	625	2	banu e	GPE
dpc-2653	625	3	medioni j	ORG
dpc-2653	625	4	ebenezer c	ORG
dpc-2653	625	5	2	CARDINAL
dpc-2653	627	1	2008;112(7):1625–31	CARDINAL
dpc-2653	627	2	32	CARDINAL
dpc-2653	628	1	ko yj	PERSON
dpc-2653	628	2	canil cm	PERSON
dpc-2653	628	3	mukherjee	PERSON
dpc-2653	628	4	second	ORDINAL
dpc-2653	628	5	2	CARDINAL
dpc-2653	629	1	lancet	ORG
dpc-2653	631	1	2013;14(8):769–76	CARDINAL
dpc-2653	631	2	2045(13)70162	CARDINAL
dpc-2653	632	1	yamamoto y	PERSON
dpc-2653	632	2	kawano	PERSON
dpc-2653	633	1	onco	PERSON
dpc-2653	634	1	2011;4:123–36	CARDINAL
dpc-2653	635	1	34	CARDINAL
dpc-2653	636	1	de giorgi u. taxane	ORG
dpc-2653	639	1	2015;16(7):e310–1	ORDINAL
dpc-2653	640	1	4 35	CARDINAL
dpc-2653	641	1	capriotti k	PERSON
dpc-2653	641	2	lessin s	PERSON
dpc-2653	641	3	wu s	PERSON
dpc-2653	641	4	goldfarb s	PERSON
dpc-2653	641	5	belum vr	PERSON
dpc-2653	644	1	2015;173(3):842–5	CARDINAL
dpc-2653	645	1	36	CARDINAL
dpc-2653	646	1	sanmartín o	PERSON
dpc-2653	646	2	beato c	ORG
dpc-2653	647	1	the spanish academy	ORG
dpc-2653	647	2	spanish	NORP
dpc-2653	649	1	2019;110(6):448–59	CARDINAL
dpc-2653	650	1	37	CARDINAL
dpc-2653	651	1	rubin ai	PERSON
dpc-2653	651	2	nj	ORG
dpc-2653	651	3	ralph daniel c	PERSON
dpc-2653	651	4	scher rk	PERSON
dpc-2653	651	5	scher	PERSON
dpc-2653	651	6	daniel	PERSON
dpc-2653	651	7	fourth	ORDINAL
dpc-2653	652	1	scher daniel’s	PERSON
dpc-2653	652	2	fourth	ORDINAL
dpc-2653	653	1	38	CARDINAL
dpc-2653	654	1	baran & dawber’s	ORG
dpc-2653	656	1	1	CARDINAL
dpc-2653	657	1	2002	DATE
dpc-2653	658	1	103–103	CARDINAL
dpc-2653	658	2	39	CARDINAL
dpc-2653	659	1	eng ht	PERSON
dpc-2653	659	2	chan a.	PERSON
dpc-2653	660	1	ann pharmacother	PERSON
dpc-2653	661	1	2009;43(10):1658–66	CARDINAL
dpc-2653	663	1	anadkat mj	PERSON
dpc-2653	663	2	bensadoun rj	PERSON
dpc-2653	663	3	bryce j	PERSON
dpc-2653	663	4	chan	PERSON
dpc-2653	663	5	epstein jb	PERSON
dpc-2653	666	1	2011;19(8):1079–95	CARDINAL
dpc-2653	667	1	41	CARDINAL
dpc-2653	668	1	reyes-habito cm	ORG
dpc-2653	668	2	roh ek	PERSON
dpc-2653	669	1	j am	PERSON
dpc-2653	672	1	jaad.2014.04.013 42	FAC
dpc-2653	673	1	apalla z	PERSON
dpc-2653	673	2	papageorgiou	PERSON
dpc-2653	673	3	delli	PERSON
dpc-2653	675	1	dermatol pract	ORG
dpc-2653	676	1	2021;11(1):e2021155	CARDINAL
dpc-2653	676	2	43	DATE
dpc-2653	677	1	2021	CARDINAL
dpc-2653	677	2	european	NORP
dpc-2653	678	1	44	CARDINAL
dpc-2653	679	1	meyer n	PERSON
dpc-2653	679	2	delord jp	PERSON
dpc-2653	680	1	dermatologic complications	PERSON
dpc-2653	680	2	anti-pd-1	NORP
dpc-2653	681	1	curr opin	PERSON
dpc-2653	681	2	oncol.	DATE
dpc-2653	682	1	45	CARDINAL
dpc-2653	684	1	j clin	PERSON
dpc-2653	687	1	017-0336	CARDINAL
dpc-2653	688	1	hain	PERSON
dpc-2653	688	2	veta-marie vm	ORG
dpc-2653	690	1	2009;15(3):143–55	ORG
dpc-2653	691	1	47	DATE
dpc-2653	692	1	piraccini bm	PERSON
dpc-2653	692	2	alessandrini a. drug-	PERSON
dpc-2653	693	1	clin	PERSON
dpc-2653	695	1	2013;31(5):618–26	ORDINAL
dpc-2653	696	1	2023;13(1):e2023064 70	CARDINAL
dpc-2653	697	1	mackay-wiggan j	PERSON
dpc-2653	697	2	nair kg	PERSON
dpc-2653	701	1	71	CARDINAL
dpc-2653	702	1	ghetti e	PERSON
dpc-2653	702	2	piraccini bm	PERSON
dpc-2653	702	3	tosti a. onycholysis	PERSON
dpc-2653	705	1	72	DATE
dpc-2653	706	1	ga	ORG
dpc-2653	706	2	kohn ec	PERSON
dpc-2653	706	3	christian mc	PERSON
dpc-2653	706	4	davis p	PERSON
dpc-2653	706	5	adamo	PERSON
dpc-2653	707	1	taxol®	ORG
dpc-2653	709	1	1995;13(3):261–3	CARDINAL
dpc-2653	710	1	73	CARDINAL
dpc-2653	711	1	wasner g	PERSON
dpc-2653	712	1	lancet	PERSON
dpc-2653	714	1	74	DATE
dpc-2653	715	1	daniel cr	PERSON
dpc-2653	717	1	clin	PERSON
dpc-2653	718	1	2013;31(5):578–86.	CARDINAL
dpc-2653	719	1	75	CARDINAL
dpc-2653	720	1	boucher kw	PERSON
dpc-2653	720	2	davidson k	PERSON
dpc-2653	720	3	goldberg j	PERSON
dpc-2653	720	4	heymann	PERSON
dpc-2653	721	1	cetuximab	PERSON
dpc-2653	723	1	2002	DATE
dpc-2653	724	1	47(4):632–3	CARDINAL
dpc-2653	724	2	76	DATE
dpc-2653	725	1	nakano j	PERSON
dpc-2653	725	2	nakamura m. paronychia	PERSON
dpc-2653	726	1	5	CARDINAL
dpc-2653	728	1	2003;30(3):261–2	CARDINAL
dpc-2653	730	1	huang kl	PERSON
dpc-2653	730	2	lin ky	PERSON
dpc-2653	730	3	huang tw	PERSON
dpc-2653	730	4	loh ew	PERSON
dpc-2653	730	5	hua ym	PERSON
dpc-2653	730	6	su hc	PERSON
dpc-2653	734	1	chanez	ORG
dpc-2653	734	2	j-f.	PERSON
dpc-2653	735	1	oncol	TIME
dpc-2653	736	1	2010;06:17	CARDINAL
dpc-2653	737	1	79	DATE
dpc-2653	738	1	dawid-pać r. medicinal	PERSON
dpc-2653	740	1	2013;30(3):170–7	CARDINAL
dpc-2653	741	1	80	CARDINAL
dpc-2653	742	1	mq	ORG
dpc-2653	742	2	hupe m	ORG
dpc-2653	742	3	mauro	ORG
dpc-2653	742	4	elias pm	PERSON
dpc-2653	745	1	81	CARDINAL
dpc-2653	745	2	wollina u	PERSON
dpc-2653	745	3	abdel-naser	PERSON
dpc-2653	746	1	clin	PERSON
dpc-2653	748	1	2020;38(6):693–701	CARDINAL